Literature DB >> 6380294

A preliminary study of factors influencing perception of menstrual blood loss volume.

I S Fraser, G McCarron, R Markham.   

Abstract

Sixty-nine women with a convincing complaint of menorrhagia took part in a double-blind treatment trial. Menstrual blood loss was measured and the subject's own perception was carefully recorded. Only 38% had objective menorrhagia with a measured loss greater than 80 ml although 59% would qualify with an upper limit of normal of 60 ml. Overall the measured loss in the "heaviest" periods (69.6 +/- 7.3 ml; mean +/- SEM) were significantly greater than that of the "lightest" periods (42.7 +/- 4.7 ml; p less than 0.001), but there were many major errors in perception by individuals. Perceived daily blood loss volume on a 4-point rating scale gave the following group means and ranges: spotting, 2.5 ml (0.1 to 15.5); light, 5.7 ml (0.1 to 63.1); moderate, 16.1 ml (0.5 to 108.6); very heavy, 22.0 ml (1.4 to 215.8); very wide individual ranges of assessment are illustrated. As a whole the group was also able to distinguish between a day-to-day volume increase or decrease, but again there were many major errors. Some subjects who experienced a reduction in measured blood loss from one day to the next actually perceived this as a large increase. Menstrual pain and duration of bleeding were not found to influence perception of blood loss volume, whereas younger subjects (26 and under) were significantly more likely than older women (37 and over) to regard a moderate loss as very heavy. There was no significant correlation between the number of pads/tampons used and the measured menstrual loss, and some individuals showed extreme variations between blood loss and pad usage. This study suggests that the only reliable assessment of menstrual blood loss volume and changes in volume in women complaining of menorrhagia is obtained by objective measurement of blood loss by a technique such as alkaline hematin extraction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6380294     DOI: 10.1016/0002-9378(84)90123-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  19 in total

1.  The natural course of spontaneous miscarriage: analysis of signs and symptoms in 188 expectantly managed women.

Authors:  Margreet Wieringa-de Waard; Willem M Ankum; Gouke J Bonsel; Jeroen Vos; Petra Biewenga; Patrick J Bindels
Journal:  Br J Gen Pract       Date:  2003-09       Impact factor: 5.386

Review 2.  Managing menorrhagia.

Authors:  A Coulter; A Long; J Kelland; S O'Meara; M Sculpher; F Song; T A Sheldon
Journal:  Qual Health Care       Date:  1995-09

3.  Referral for menstrual problems: cross sectional survey of symptoms, reasons for referral, and management.

Authors:  P Warner; H O Critchley; M A Lumsden; M Campbell-Brown; A Douglas; G Murray
Journal:  BMJ       Date:  2001-07-07

Review 4.  Outcome measures for heavy menstrual bleeding.

Authors:  Stephen D Quinn; Jenny Higham
Journal:  Womens Health (Lond)       Date:  2015-12-23

5.  Heavy menstrual bleeding: delivering patient-centred care.

Authors:  Miriam Santer
Journal:  Br J Gen Pract       Date:  2008-03       Impact factor: 5.386

6.  A comparative study of danazol and norethisterone in dysfunctional uterine bleeding presenting as menorrhagia.

Authors:  M Bonduelle; J J Walker; A A Calder
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

Review 7.  Management of menorrhagia.

Authors:  A L Magos
Journal:  BMJ       Date:  1990-06-16

8.  Menorrhagia.

Authors:  M Rees
Journal:  Br Med J (Clin Res Ed)       Date:  1987-03-21

9.  Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding.

Authors:  Magdalena Bofill Rodriguez; Anne Lethaby; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2019-09-19

10.  Patient satisfaction following transcervical resection of the endometrium.

Authors:  F McAuliffe; J English; W Prendiville
Journal:  Ir J Med Sci       Date:  1996 Jul-Sep       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.